|
Clinical
activity of trastuzumab and vinorelbine in women with her2-overexpressing
metastatic breast cancer.
Burstein
HJ, Kuter I, Campos SM, et al. J Clin Oncol. 2001;19:2722-30.
From
the molecule to the clinic--inhibiting HER2 to treat breast
cancer.
Eisenhauer EA. N Engl J Med. 2001;344:841-2.
HER-2/neu
analysis in archival tissue samples of human breast cancer:
Comparison of immunohistochemistry and fluorescence in situ
hybridization.
Lebeau
A, Deimling D, Kaltz C, et al. Journal
of Clinical Oncology. 19(2):354-363, 2001 Jan 15.
Reliability
assessment of soluble c-erbB-2 concentrations in the saliva
of healthy women and men.
Streckfus
C, Bigler L, Dellinger T, et al. Oral
Surgery Oral Medicine Oral Pathology Oral Radiology &
Endodontics. 91(2):174-179, 2001 Feb.
Murine
monoclonal anti-idiotypic antibody as a surrogate antigen
for human Her-2/neu.
Baral R, Sherrat A, Das R, Foon KA, Bhattacharya-Chatterjee
M. Int J Cancer. 2001;92:88-95.
Inhibition
of Growth Factor Production and Angiogenesis in Human Cancer
Cells by ZD1839 (Iressa), a Selective Epidermal Growth Factor
Receptor Tyrosine Kinase Inhibitor.
Ciardiello
F, Caputo R, Bianco R, et al. Clin Cancer Res. 2001;7:1459-1465.
DNA-based
vaccines for the treatment of cancer - an experimental model.
Cohen EP. Trends Mol Med. 2001;7:175-9.
Comparison
of methods of measuring HER-2 in metastatic breast cancer
patients treated with high-dose chemotherapy.
Harris LN, Liotcheva V, Broadwater G, et al. J Clin Oncol.
2001;19:1698-706.
Tumor
Suppression and Therapy Sensitization of Localized and Metastatic
Breast Cancer by Adenovirus p53.
Lebedeva S, Bagdasarova S, Tyler T, Mu X, Wilson DR, Gjerset
RA. Hum Gene Ther. 2001;12:763-72.
Characterization
of (123)I-vascular endothelial growth factor-binding sites
expressed on human tumour cells: possible implication for
tumour scintigraphy.
Li S, Peck-Radosavljevic M, Koller E, et al. Int J Cancer.
2001;91:789-96.
Fluorescence
in situ hybridization and immunohistochemical assays for her-2/neu
status determination.
Onody P, Bertrand F, Muzeau F, Bieche I, Lidereau R. Arch
Pathol Lab Med. 2001;125:746-50.
Comparison
of HER2/neu status assessed by quantitative polymerase chain
reaction and immunohistochemistry.
O'Malley FP, Parkes R, Latta E, et al. Am J Clin Pathol. 2001;115:504-11.
|
